Clinical Trials Academy: Protocol Development (CTA1)
Curriculum for early-career faculty and new clinician investigators covering the complex and changing landscape of clinical and behavioral trials
Who?
Early-career faculty and new clinician investigators
When?
Applications are normally due in September/October for the next year’s cohort. Application deadlines will be shared on the MICHR news page.
How much?
Free
What is this offering?
Clinical Trials Academy: Protocol Development (CTA1) offers early-career faculty and new clinician investigators a combination of lectures and hands-on small-group sessions to teach the complex and changing landscape of clinical and behavioral trials. The curriculum is designed to construct the most pertinent hypotheses, teach the fundamentals of clinical trial design, and develop scientifically rigorous and practical protocols for a broad landscape of clinical trials. Trainees will also receive practical tips for successful collaborations among investigators with complementary expertise across divisions and departments, and industry partners.
How this advances translational science
Implementing operations that facilitate and support the quality and impact of research
Translational Science Categories: